Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article published on 13 May 2019 |
| Author/s |
author: Steve Schey Athanasios Dimopoulos Sergey Semochkin Katja Weisel Pieter Sonneveld Fredrik Hellem Schjesvold Tsvetan Biyukov Anna Marina Liberati Teresa Peluso Thierry Facon Paul G. Richardson Kenneth C. Anderson Peter H Gorman Jesús San Miguel Meral Beksac |
| Publication date | May 13, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |